Loida A Gonzalez-Rodríguez, MD UPR-Medical Sciences Campus
Gut microbiome un a sample of Hispanic patients with Polycystic Ovary Syndrome
I have focused my research efforts in understanding the high prevalence of metabolic syndrome, insulin resistance and diabetes mellitus in our population. As an endocrinologist, I see every day the detrimental effects of metabolic syndrome, insulin resistance, diabetes mellitus and cardiovascular diseases in my patients. The serious problems related to health disparities in these conditions challenges me every day igniting in me the desire to eliminate these health disparities. All these conditions have been associated with polycystic ovary syndrome (PCOS), a common endocrinopathy affecting women in reproductive years. This condition is frequently overlooked by healthcare providers since it manifests as different phenotypes, and the symptoms can be nonspecific. However, the long-term outcomes and comorbidities observed in patients with PCOS such as metabolic syndrome, cardiovascular disease, diabetes mellitus, infertility, mood disorders and endometrial cancer, are not only associated with high mortality but can be preventable with early diagnosis and treatment.I havebeen invited and participated innational advocacy groups to improve awareness, expand health care,and increase funding for PCOS research. I have also participated as mentor for medical students, residents in Internal Medicine, master’s in public health, master’s in clinical laboratory sciencesand PhD in Anatomy and Neurobiology. My previous background in clinical research and my training in endocrinology.
